Personal information

No personal information available

Activities

Collapse all

Employment (2)

Cedars-Sinai Medical Center: Los Angeles, CA, US

2011-06-21 to present | Pharmacy Program Coordinator (Pharmacy Services)
Employment
Source: Self-asserted source
Suwicha Limvorasak

University of Chicago Medical Center: Chicago, IL, US

2005-06-28 to 2011-06-20 | Clinical Pharmacist Specialist (Pharmacy)
Employment
Source: Self-asserted source
Suwicha Limvorasak

Education and qualifications (2)

University of Florida: Gainesville, FL, US

PharmD
Education
Source: Self-asserted source
Suwicha Limvorasak

Chulalongkorn University: Bangkok, TH

Bachelor Degree (Pharmaceutical Sciences)
Education
Source: Self-asserted source
Suwicha Limvorasak

Works (6)

Targeted therapies for renal cell carcinoma.

Nature reviews. Nephrology
2017-07-10 | Journal article
DOI: 10.1038/nrneph.2017.82
PMID: 28691713
Source: Self-asserted source
Suwicha Limvorasak

Third-Line Treatment Options for Kidney Cancer.

Oncology (Williston Park, N.Y.)
2016-09-01 | Journal article
PMID: 27633411
Source: Self-asserted source
Suwicha Limvorasak

Targeting angiogenesis in renal cell carcinoma.

Expert opinion on pharmacotherapy
2013-08-28 | Journal article
DOI: 10.1517/14656566.2013.832202
PMID: 23984807
Source: Self-asserted source
Suwicha Limvorasak

Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database.

Journal of clinical bioinformatics
2011-02-01 | Journal article
DOI: 10.1186/2043-9113-1-8
PMID: 21603121
PMC: PMC3164615
Source: Self-asserted source
Suwicha Limvorasak

Kinase inhibitors in prostate cancer.

Anti-cancer agents in medicinal chemistry
2009-12-01 | Journal article
DOI: 10.2174/187152009789735080
PMID: 19925393
Source: Self-asserted source
Suwicha Limvorasak

Pazopanib: therapeutic developments.

Expert opinion on pharmacotherapy
2009-12-01 | Journal article
DOI: 10.1517/14656560903436493
PMID: 19954277
Source: Self-asserted source
Suwicha Limvorasak
How many people are using ORCID?